The Path to a Cure for Type 1 Diabetes
Since its founding in 2015, Beyond Type 1 has been focused on filling gaps — whether in resources for living well today, access to life-saving medication and technologies or in education and awareness. One of the areas where we have identified a gap is in early, innovative cure research.
Since its founding in 2015, Beyond Type 1 has been focused on filling gaps—whether in resources for living well today, access to life-saving medication and technologies or in education and awareness. When we look at the cure space, we have identified a gap in early, innovative cure research and a lack of enrollment in clinical trials. These problems are stalling research and the path to a cure.
The problem
English mathematician and philosopher Alfred North Whitehead said, “Ideas won’t keep. Something must be done about them.” In regards to type 1 diabetes, not only must something be done with ideas about how to eradicate the disease or how to make life better for those living with it, but there is no time to waste.
Testing ideas with evidence is at the heart of the process of science and yet there are countless ideas locked in the minds of researchers, scholars and inventors, but mainstream funding and clinical trial participation rarely supports them.
97 percent of funding that is currently available for diabetes goes to established scientists, while scientific breakthroughs often emerge due to the inventiveness of early-career scientists. We can change this by funding early stages of cure research projects.
80-85 percent of clinical trials in the US and Canada are delayed because of lack of participation. We can do better than that. Theories need testing, and we can be a part of the solution, a part of the cure. There are a wide variety of clinical trials that get us closer to just that.
Albert Einstein revealed his theory of general relativity at 26. Banting and Best discovered insulin before they turned 33. Imagine our world today if these scientists had not received funding or clinical trial participants to test their ideas. Without a reliable and consistent source of funding, the number of researchers in diabetes is going to continue declining and without participation in our clinical trials, a cure will be that more elusive.
Participate
Many clinical trials never get off the ground because of low participation. You can think of it as a social responsibility to participate, but there are additional perks to being an active part of research such as getting expert attention on your diabetes management, receiving free goods, making a little money on the side for doing what you already do—manage your type 1 diabetes. Oh and also—helping us cure it.
Get informed
Ever wonder how treatments become available? Have you heard about “phases” of development and FDA approval? Here’s a primer on...
Read more
What is clinical research and why is it important? According to the NIH, the purpose of clinical research is to “advance medical...
Read more
If you have a relative with type 1 diabetes, you may be at higher risk of developing the disease, making...
Read more
What is TrialNet? TrialNet is an international network of the world’s leading type 1 diabetes (T1D) researchers who are exploring...
Read more
Researcher profiles
Type 1 Programs
Beyond Diagnosis
Getting diagnosed with diabetes sucks. We're making it suck less.
Get Insulin
Connecting people living with diabetes in the United States to the insulin access and affordability...
Type 1 Community
Join the Beyond Type 1 Community, a safe space for those with type 1 diabetes...
Community Table
Every month, all year long, Beyond Type 1 hosts conversations around under-discussed issues facing the...
Beyond Scholars
Empowering success through education for people living with diabetes.
Marathon Team
Beyond Type Run, a program of Beyond Type 1, brings together an inspiring team of...
Beyond Barriers
Together we can transform lives. Together we are going Beyond Barriers.
See The Signs
Become a #SeeTheSigns Ambassador for Beyond Type 1 and help save lives by sharing a...